SEC 13F Intelligence

Reynders Mcveigh Capital Management, LLC / ABT

Reynders Mcveigh Capital Management, LLC’s Abbott Laboratories Position

Does Reynders Mcveigh Capital Management, LLC own Abbott Laboratories (ABT)? Yes — 421.7K shares worth $43M (+2.18% of its 13F portfolio) as of Q1 2026, up from 419.9K shares the prior filed quarter.

Position Value
$43M
Q1 2026
Shares
421.7K
% of Portfolio
+2.18%
Quarters Held
28
currently held

Position History ABT

Reported value by quarter
Q1 ’19: $25MQ1 ’19Q2 ’19: $26MQ3 ’19: $26MQ4 ’19: $29MQ1 ’20: $27MQ1 ’20Q2 ’20: $33MQ3 ’20: $41MQ4 ’20: $42MQ1 ’21: $46MQ1 ’21Q2 ’21: $44MQ3 ’21: $46MQ4 ’21: $55MQ1 ’22: $46MQ1 ’22Q2 ’22: $42MQ3 ’22: $38MQ4 ’22: $43MQ1 ’23: $39MQ1 ’23Q2 ’23: $42MQ3 ’23: $38MQ4 ’23: $42MQ1 ’24: $45MQ1 ’24Q2 ’24: $42MQ3 ’24: $46MQ4 ’24: $46MQ1 ’25: $54MQ1 ’25Q3 ’25: $56MQ4 ’25: $53MQ1 ’26: $43Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026421.7K$43M+2.18%
Q4 2025419.9K$53M+2.47%
Q3 2025419.0K$56M+2.63%
Q1 2025409.6K$54M+3.03%
Q4 2024409.7K$46M+2.44%
Q3 2024406.7K$46M+2.46%
Q2 2024401.7K$42M+2.37%
Q1 2024396.2K$45M+2.59%
Q4 2023386.0K$42M+2.69%
Q3 2023387.5K$38M+2.58%
Q2 2023383.5K$42M+2.74%
Q1 2023385.3K$39M+2.68%
Q4 2022388.2K$43M+3.13%
Q3 2022392.5K$38M+2.95%
Q2 2022390.2K$42M+3.18%
Q1 2022392.1K$46M+2.84%
Q4 2021392.0K$55M+3.13%
Q3 2021391.0K$46M+2.83%
Q2 2021383.6K$44M+2.72%
Q1 2021379.8K$46M+3.03%
Q4 2020379.2K$42M+2.84%
Q3 2020372.5K$41M+3.13%
Q2 2020356.1K$33M+2.85%
Q1 2020337.8K$27M+3.04%
Q4 2019331.4K$29M+2.77%
Q3 2019310.2K$26M+2.77%
Q2 2019305.7K$26M+2.76%
Q1 2019311.6K$25M+2.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Reynders Mcveigh Capital Management, LLC’s full portfolio or all institutional holders of ABT.